ContraFect Corporation (CFRX) Suffers Falling Market Confidence
Wasim Omar
January 27, 2023
ContraFect Corporation (NASDAQ: CFRX) is a clinical-stage biotech player which focuses primarily on antibody-based treatments and several strains of protein material as therapy. CFRX stock